Suprenza is owned by Citius Pharms.
Suprenza contains Phentermine Hydrochloride.
Suprenza has a total of 1 drug patent out of which 0 drug patents have expired.
Suprenza was authorised for market use on 13 June, 2011.
Suprenza is available in tablet, orally disintegrating;oral dosage forms.
The generics of Suprenza are possible to be released after 14 March, 2029.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US8440170||CITIUS PHARMS||Orally disintegrating tablets with speckled appearance|| |
(5 years from now)
Drugs and Companies using PHENTERMINE HYDROCHLORIDE ingredient
Market Authorisation Date: 13 June, 2011
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic